Carl Zeiss Meditec Ag (CZMWF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, ladies and gentlemen, and welcome to the Carl Zeiss Meditech AG analyst conference for the six months 2025 results. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions following the presentation. Let me now turn the floor over to your host, Sebastian Frerich, head of investor relations. Welcome, everybody. Thanks for joining the call on our six months results. With me, as usual, our president and CEO, Dr. Markus Weber, and our CFO, Justus Wehmer. And they will take you in just a moment through our half-year results, talk about our financials, and discuss some recent key highlights. And after that, we look forward to your questions. Today, we have a special guest. We have also invited Maximilian Fröst, the incoming CEO of Carthage Meditech, as of June 1st, as we have announced last week, to join the call for a brief introduction at the end of the prepared remarks. And with that being said, I would like to hand over to you, Markus, to start the call. Yeah, thank you so much, Sebastian, and also a warm welcome. Good morning from my side, ladies and gentlemen. Welcome to the six-month, 24-25, Analyst Conference of Carl Zeiss Meditech AG. So first of all, and actually Sebastian already mentioned that with my successor, I want to address last week's news that I'm stepping down from the CEO role at the end of May. Actually, I have recently decided after more than 22 years with ZEISS, with the company, to seek a new challenge outside of the company. Now it's the right time for me and my family to take the step As I strongly feel, I'm able to lead the company in very good shape and in good hands. The initiatives we put in place during the last year are beginning to pay off. New product introductions are ramping up...